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Genetic suppression of insulin/insulin-like growth factor signaling (IIS) can extend longevity
in worms, insects, and mammals. In laboratory mice, mutations with the greatest, most
consistent, and best documented positive impact on lifespan are those that disrupt growth
hormone (GH) release or actions. These mutations lead to major alterations in IIS but also
have a variety of effects that are not directly related to the actions of insulin or insulin-
like growth factor I. Long-lived GH-resistant GHR-KO mice with targeted disruption of the
GH receptor gene, as well as Ames dwarf (Prop1df) and Snell dwarf (Pit1dw) mice lacking
GH (along with prolactin and TSH), are diminutive in size and have major alterations in
body composition and metabolic parameters including increased subcutaneous adiposity,
increased relative brain weight, small liver, hypoinsulinemia, mild hypoglycemia, increased
adiponectin levels and insulin sensitivity, and reduced serum lipids. Body temperature
is reduced in Ames, Snell, and female GHR-KO mice. Indirect calorimetry revealed that
both Ames dwarf and GHR-KO mice utilize more oxygen per gram (g) of body weight
than sex- and age-matched normal animals from the same strain. They also have reduced
respiratory quotient, implying greater reliance on fats, as opposed to carbohydrates, as
an energy source. Differences in oxygen consumption (VO2) were seen in animals fed
or fasted during the measurements as well as in animals that had been exposed to 30%
calorie restriction or every-other-day feeding. However, at the thermoneutral temperature of
30◦C,VO2 did not differ between GHR-KO and normal mice.Thus, the increased metabolic
rate of the GHR-KO mice, at a standard animal room temperature of 23◦C, is apparently
related to increased energy demands for thermoregulation in these diminutive animals.We
suspect that increased oxidative metabolism combined with enhanced fatty acid oxidation
contribute to the extended longevity of GHR-KO mice.
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INTRODUCTION: GROWTH HORMONE-RELATED MOUSE
MUTANTS
Studies of hypopituitary, growth hormone (GH) deﬁcient, and
GH-resistant mice provided evidence that deletion of GH signals
can produce an impressive extension of longevity (Brown-Borg
et al., 1996; Flurkey et al., 2001; Coschigano et al., 2003). Mice
lacking GH or GH receptors show numerous symptoms of delayed
aging, are partially protected from age-related diseases, and outlive
their normal siblings by 30–65% depending on genetic back-
ground, sex, and diet composition (reviewed in Bartke, 2011;
Bartke, 2012; Brown-Borg and Bartke, 2012). Candidate mech-
anisms linking the absence of GH signals with extension of
longevity include altered expression of numerous genes related
to glucose homeostasis, protein synthesis, lipogenesis, lipoly-
sis, and energy metabolism (Tsuchiya et al., 2004; Al-Regaiey
et al., 2005; Papaconstantinou et al., 2005; Masternak and Bartke,
2007). Apparently, anti-aging effects of reduced GH signaling
involve metabolic adjustments of which some resemble those that
mediate the effects of calorie restriction (CR) on aging and
longevity (Tsuchiya et al., 2004; Al-Regaiey et al., 2005; Bonkowski
et al., 2009).
In this brief review, we will discuss metabolic characteristics of
GH-deﬁcient and GH-resistant mice which are likely to represent
mechanisms of their extended longevity. Metabolic characteristics
of other long-lived mutants, gene knockouts and transgenics as
well as phenotypes of mice from strainswith different longevity are
outside the scope of this article, and the reader is referred to other
reviews (Brown-Borg, 2006; Chen et al., 2010; Yuan et al., 2011).
ROLE OF IMPROVED INSULIN SIGNALING
Improved action of insulin on carbohydrate homeostasis is among
the key metabolic alterations in long-lived GH-related mutants.
GH receptor disrupted GHR-KO mice with profound GH resis-
tance (Zhou et al., 1997), GH releasing hormone disrupted
(GHRH-KO) mice with isolated GH deﬁciency (Alba and Salva-
tori, 2004), and hypopituitary Ames (Prop1df ) and Snell (Pit1dw)
dwarf mice with deﬁciency of GH, along with prolactin and thy-
rotropin (Bartke,2011; Brown-Borg andBartke,2012; Bartke et al.,
in press), have reduced insulin levels and enhanced insulin sen-
sitivity (Zhou et al., 1997; Bonkowski et al., 2006; Bartke, 2011;
Bartke, 2012; Brown-Borg and Bartke, 2012; Spong and Bartke,
unpublished). Since hypoinsulinemia promotes insulin sensitivity
and vice versa, it could be debated which of these characteristics is
primary and which is secondary. However, available evidence sug-
gests that reduction in GH signals affects both the secretion and
actions of insulin. GH and insulin-like growth factor I (IGF-I), a
key mediator of GH action, promote development and secretory
function of insulin-producing beta cells in the islets of Langerhans
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in the pancreas. Islet volume is reduced in GHR-KO mice (Guo
et al., 2005), and the number of large islets is reduced in Ames
dwarf mice (Parsons et al., 1995). Insulin sensitivity is negatively
regulated by GH by a variety of mechanisms including reduced
adiponectin levels, enhanced mammalian target of rapamycin
(mTOR) signaling, and alterations in serum lipid proﬁles as well as
ectopic fat accumulation. Many of these effects of GH on insulin
signaling are mediated by enhanced inhibitory (serine) phospho-
rylation of insulin receptor substrate 1 (IRS-1; Aguirre et al., 2002;
Ishizuka et al., 2004; Adochio et al., 2009). All of these mecha-
nisms appear to be involved in improving insulin sensitivity in
GH-related mouse mutants (Al-Regaiey et al., 2005; Wang et al.,
2006; Bonkowski et al., 2009; List et al., 2011).
ROLE OF ADIPOSE TISSUE AND ITS PRODUCTS IN THE
METABOLIC PROFILE OF GH-RELATED MUTANTS
We have recently obtained evidence that enhanced insulin sensi-
tivity of long-lived GHR-KO mice is due to the altered secretory
proﬁle of intra-abdominal (“visceral”) adipose tissue and, in par-
ticular, to enhanced adiponectin secretion by these fat depots.
It is well documented that adiponectin is an important insulin
sensitizer. In comparison to normal mice, GHR-KO mutants have
increased levels of adiponectin in the epididymal fat and in periph-
eral circulation (Al-Regaiey et al., 2005; List et al., 2011). To assess
the impact of altered secretory activity of visceral fat on insulin
signaling, we have compared the impact of removing most of this
tissue on insulin and glucose tolerance in thesemutants versus nor-
mal mice. We removed as much of the epididymal and perinephric
(retroperitoneal) fat pads as was possible without endangering
blood supply to the testes and the adrenals. In normal mice this
resulted in signiﬁcant improvements in insulin and glucose tol-
erance (Masternak et al., 2012) as expected from previous studies
in this and other species (Shi et al., 2007; Muzumdar et al., 2008).
Plasma adiponectin levels were not altered, indicating that in these
animals circulating adiponectin is derived primarily from subcu-
taneous fat, or that other fat depots readily compensate for the
consequences of removing visceral fat. In sharp contrast to these
ﬁndings, visceral fat removal in GHR-KO mice reduced circulating
adiponectin levels and reduced, rather than enhanced, tolerance
to injected insulin or glucose (Masternak et al., 2012). Apparently,
visceral fat is a major source of adiponectin in these animals and
visceral fat-derived adiponectin importantly contributes to or per-
haps accounts for enhanced insulin sensitivity of GHR-KO mice.
In addition to differences in the levels of adiponectin, the lev-
els of interleukin 6 (IL-6), which promotes insulin resistance, are
reduced in both epididymal and perinephric fat of GHR-KO as
compared to normal mice (Masternak et al., 2012). Altered IL-6
levels may have also contributed to the differential impact of vis-
ceral fat removal on insulin sensitivity in GHR-KO versus normal
mice.
INTERACTIONS OF CALORIE RESTRICTION AND GH-RELATED
MUTATIONS
Association of reduced insulin levels and enhanced insulin sen-
sitivity with extension of longevity was shown in a comparison
of GH-related mutants (GHR-KO, GHRH-KO, Prop1df , Pit1dw)
with their normal siblings and in studies of the interaction of
some of these “longevity genes” with CR (Masternak et al., 2009).
Strikingly, CR improves insulin signaling in Ames dwarf mice, in
which it also extends longevity (Bartke et al., 2001;Masternak et al.,
2009), but has no such effect in GHR-KO mice or in GHRH-KO
males in which effects of CR on longevity are absent or mini-
mal (Bonkowski et al., 2006, 2009; Spong, Salvatori, and Bartke,
unpublished). Moreover, longevity is not enhanced in transgenic
mice overexpressing a GH antagonist in which insulin levels are
not suppressed (Coschigano et al., 2003). It deserves emphasis that
a reduction in insulin levels and enhancement of insulin sensitiv-
ity are among the most consistently observed responses to CR in
different mammalian species ranging from mice and rats to non-
human primates and humans (Fontana et al., 2004; Anderson and
Weindruch, 2012).
In contrast to the strong association of improved insulin sig-
naling with extended longevity in GH-related mutants, several
mutations affecting events “downstream” from GH and/or IGF-I
receptors are long-lived and insulin resistant (Kurosu et al., 2005;
Selman et al., 2009). Further work, including examination of
insulin signaling at different stages of life history will be needed to
reconcile these ﬁndings but possible explanations include the well-
documented opposite effects of GHand IGF-I on insulin signaling,
as well as a possibility that insulin resistance may mimic some of
the effects of hypoinsulinemia by protecting the cells from exces-
sive insulin stimulation (Taguchi et al., 2007; Selman et al., 2009).
INFLAMMATION MARKERS AND METABOLIC
ADJUSTMENTS
In addition to inﬂuencing glucose homeostasis, suppression of
GH signaling promotes β oxidation of fatty acids. Fatty acid oxi-
dation is promoted by the direct or indirect actions of peroxisome
proliferator activator receptor α (PPARα), PPARγ coactivator
1α (PGC1α), ﬁbroblast growth factor 21 (FGF-21), adiponectin,
and AMP-activated protein kinase (AMPK) – and GH negatively
regulates the expression or activation of each of these factors (Al-
Regaiey et al., 2005; Masternak and Bartke, 2007; Bonkowski et al.,
2009; Louis et al., 2010). Increases in the levels of adiponectin
and activation of AMPK in GH-resistant and GH-deﬁcient ani-
mals also reduce pro-inﬂammatory signals by inhibiting nuclear
factor kappa B (NFκB) signaling (Salminen et al., 2011; Mas-
ternak and Bartke, 2012). The resulting shift in the balance of
pro- and anti-inﬂammatory cytokines constitutes yet another
potential mechanism of enhancing insulin sensitivity (Salmi-
nen et al., 2011). Association of an altered balance of pro- and
anti-inﬂammatory markers with shifts in carbohydrate and lipid
homeostasis in long-lived GH-related mutants can thus be related
to the involvement of the same mediators of GH action in the
control of inﬂammation and metabolism.
MITOCHONDRIAL FUNCTION AND OXIDATIVE METABOLISM
Enhanced hepatic expression of PGC1α and reduced serum lipid
levels inGH-resistantmice (Al-Regaiey et al., 2005; List et al., 2011)
suggest alterations in the number and function of mitochondria.
PGC1α is a key regulator of mitochondrial biogenesis, and mito-
chondrial utilization of fatty acids as a metabolic fuel has a major
impact on lipid homeostasis and circulating lipid levels.
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There is little information on the number or morphology of
mitochondria in long-lived GH-related mutants, while available
data suggest lack of major changes in mitochondrial density in
the liver or muscle of GHR-KO mice (Westbrook et al., unpub-
lished). In Ames dwarf mice, generation of reactive oxygen species
(ROS) by the skeletal muscle mitochondria is reduced, suggesting
improved mitochondrial efﬁciency (Brown-Borg, 2006).
We are using indirect calorimetry to study the impact of GH
signaling on energy metabolism. Twenty-four hour recordings of
oxygen consumption and carbondioxide output revealed that oxy-
gen consumption (VO2) per gram of body weight is signiﬁcantly
increased and respiratory quotient (RQ) signiﬁcantly reduced in
Ames dwarf and GHR-KO mice (Westbrook et al., 2009).
These differences were present whether the animals were fed
ad libitum or fasted during the recording (Westbrook et al., 2009).
Moreover, similar differences between GHR-KO and normal mice
were detected after exposing the animals to a prolonged period of
caloric restriction or every-other-day-feeding (Westbrook et al.,
unpublished). Interestingly, opposite changes (reduced VO2 and
increased RQ) were seen in giant PEPCK-bGH transgenic mice
which are hypersomatotropic, hyperinsulinemic, insulin resistant,
and short-lived (Bartke,2003;Westbrook et al., 2009). The increase
of VO2 in GHR-KO and Ames dwarf mice was apparently not
due to expressing the data per unit of body mass, because dif-
ferences between mutant and normal animals were, if anything,
magniﬁed when the data were recalculated per unit of lean body
mass (as determined by DEXA in age- and sex-matched mice;
Westbrook, 2012).
Detecting this increase in VO2 was not anticipated particu-
larly in Ames dwarf mice which are hypothyroid and hypothermic
and have reduced spontaneous locomotor activity (Bartke, 2011;
Bartke, 2012; Brown-Borg and Bartke, 2012). Moreover, VO2 was
reported to be reduced in Snell dwarf mice which phenotypically
resemble the Ames dwarfs (Benedict and Lee, 1936). We suspected
that the increase of VO2 in GH-related mutants could reﬂect
increased energy expenditure for thermogenesis needed to com-
pensate for increased heat loss. Increased radiation of heat would
be expected in these diminutive animals because of the increased
body surface to mass ratio. To test the validity of this explanation,
we have compared VO2 in GHR-KO and normal mice at a ther-
moneutral ambient temperature of 30◦C. Under these conditions,
VO2 of the mutants greatly declined from the values measured at
lower temperature and no longer differed from the normal ani-
mals (Westbrook et al., unpublished). We conclude that increased
VO2 in long-lived dwarf mice reﬂects increased energy demand for
thermogenesis under conditions imposed by housing at the stan-
dard animal room ambient temperature (approximately 22◦C).
It is an intriguing possibility that this increase in energy expen-
diture might contribute to slow aging and extended longevity of
these mutants. Koizumi et al. (1996) reported that the beneﬁcial
impact of CR on cancer incidence and longevity in mice can be
reduced or eliminated by housing the animals at a thermoneutral
temperature. However, these authors suggested that the effects of
thermoneutral temperature in their study were due to eliminating
torpor which was a common (daily) occurrence under the condi-
tions of fairly severe CR they employed (Koizumi et al., 1996). We
very rarely observe torpor in our animals.
Since metabolic rate declines during aging, an increase in VO2
in long-lived mutant mice could be viewed either as a potential
mechanism of extended longevity or as a “biomarker” of delayed
and/or slower aging. Association of increased metabolic rate with
improved life expectancy might be due to the beneﬁts of increased
uncoupling of mitochondrial electron transport from ATP pro-
duction (Brand, 2000) and activation of AMPK. Reduced mTOR
signaling and S6K activity in Ames dwarf and GHRKO mice
(reviewed in Bartke, 2011) may provide yet another link between
the regulation of aging, oxidative metabolism, and energy sub-
strate utilization. It was recently reported that a leucine-deﬁcient
diet which suppresses hypothalamic S6KI activity produces an
increase in VO2 per unit of body mass and a reduction in RQ;
these are alterations similar to those we detected in long-lived
dwarf mice (Xia et al., 2012). Examples of the association of
increased VO2 and reduced RQ with resistance to detrimental
effects of high fat diet are provided in the next section of this
article.
ALTERED USAGE OF ENERGY SUBSTRATES
In addition to demonstrating an increase in VO2, indirect
calorimetry studies of Ames dwarf and GHR-KO mice revealed
another metabolic characteristic of these long-lived animals,
namely a reduction of RQ. As was the case with VO2, these
differences were detected during both dark (active) and light
(resting) parts of the 24-h period, were present in both fully
fed and fasted animals, and were opposite to changes mea-
sured in short-lived giant PEPCK-GH transgenics (Westbrook
et al., 2009). Reduced RQ values indicate increased reliance on
fat, as opposed to carbohydrate, as a metabolic fuel and thus
denote an important shift in mitochondrial function. Increased
“fat burning” by mitochondria is believed to be associated with
improved metabolic efﬁciency and reduced production of poten-
tially harmful ROS (Lopez-Lluch et al., 2006; Ukropcova et al.,
2007; Anderson and Weindruch, 2010). Similar metabolic adjust-
ments are associated with extension of longevity in animals
exposed to CR (Anderson and Weindruch, 2010). Moreover,
reduced RQ and enhanced VO2 were associated with protection
from high fat diet-induced obesity, glucose intolerance and dia-
betes in mice with ablated agouti-related protein (AgRP) produc-
ing neurons and in retinaldehyde dehydrogenase 1a1 knock-out
mice (Joly-Amado et al., 2012; Kiefer et al., 2012). Likely mech-
anisms of increased β oxidation of fatty acids in GHRKO and
Ames dwarf mice include increases in adiponectin levels (Al-
Regaiey et al., 2005; List et al., 2011), activation of AMPK (Al-
Regaiey et al., 2005), and expression of hepatic PPARα (Masternak
and Bartke, 2007).
In contrast, to ﬁndings in Ames dwarf and GHR-KO mice,
extended longevity in mice with fat-speciﬁc deletion of insulin
receptors, as well as improvement of the metabolic proﬁle of obese
mice after gastric bypass, are associated with increases in bothVO2
and RQ (Katic et al., 2007; Nestoridi et al., 2012). From the data
that are currently available, it is difﬁcult to determine whether
the association of increased VO2 and reduced RQ in long-lived
GH-related mutants is in any way related to the uncommon asso-
ciation of increased obesity with reduced insulin and increased
adiponectin levels in these animals.
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FIGURE 1 | Metabolic alterations in GH-deficient and GH-resistant mice; possible mechanisms of extended longevity.
SUMMARY AND RELATIONSHIP TO REGULATION OF
HUMAN AGING
The remarkable extension of longevity in mice lacking GH or GH
receptors appears to be due to multiple interacting mechanisms
including reduced activation of growth-promoting pathways,
greater stress resistance, reduced inﬂammation, increased reser-
voir of pluripotent stem cells, and improved genome maintenance
(Flurkey et al., 2001; Coschigano et al., 2003;Murakami et al., 2003;
Garcia et al., 2008; Bokov et al., 2009; Bartke, 2011; Ratajczak et al.,
2011; Bartke, 2012; Brown-Borg and Bartke, 2012). Data summa-
rized in this article indicate that alterations in energy metabolism
and improved insulin control of carbohydrate homeostasis have to
be added to this list. In fact, these metabolic adaptations may rep-
resent key features of the “longevous” phenotype of these animals
and important mechanisms of the extension of both healthspan
and lifespan in GH-related mutants (Figure 1).
Importantly, many of the metabolic features of long-lived
mutant mice described in this article have been associated
with extended human longevity. Comparisons between cen-
tenarians and elderly individuals from the same population
and between the offspring of exceptionally long-lived people
and their partners indicate that reduced insulin, improved
insulin sensitivity, increased adiponectin, and reduced pro-
inﬂammatory markers consistently correlate with improved life
expectancy (Kojima et al., 2004; Atzmon et al., 2006; Baranowska
et al., 2006; Bonafè andOlivieri, 2009; Rozing et al., 2011;Wijsman
et al., 2011).
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